Table 1 Comparison of clinical data (x ± s).

Age (years)

56.53 ± 10.94

59.27 ± 12.79

0.126

Sexuality

M 230 (85.5%)

F 39 (14.5%)

M 36 (87.8%)

F 5 (12.2%)

0.694

BMI (kg/m²)

25.47 ± 3.58

25.95 ± 3.35

0.603

LVEF (%)

60.10 ± 4.94

58.56 ± 5.02

0.531

Clinical diagnosis

 STEMI

135 (50.2%)

28 (68.3%)

0.114

 NSTEMI

134 (49.8%)

13 (31.7%)

Laboratory examination

 Hemoglobin (g/L)

137.75 ± 17.36

137.68 ± 15.35

0.980

 BNP (pg/mL)

100.87 ± 135.14

134.06 ± 146.25

0.088

 Total cholesterol (mmol/L)

4.12 ± 1.10

3.78 ± 1.20

0.907

 Triglyceride (mmol/L)

1.85 ± 2.20

1.74 ± 0.94

0.601

 Low-density lipoprotein (mmol/L)

2.40 ± 1.50

2.16 ± 0.90

0.763

 High-density lipoprotein (mmol/L)

1.03 ± 0.33

1.04 ± 0.24

0.784

 Serum creatinine (µmol/L)

66.79 ± 27.26

65.71 ± 23.06

0.428

 Troponin (µg/L)

2.66 ± 6.90

1.09 ± 2.06

0.052

 Creatine kinase-MB (U/L)

1.43 ± 2.88

1.25 ± 1.12

0.360

Smoking history

 Never or have quit smoking

159 (59.1%)

21 (51.2%)

0.340

 Smoking

110 (40.9%)

20 (48.8%)

Drinking history

 Never or have quit drinking

188 (69.9%)

25 (60.9%)

0.488

 Drinking

81 (30.1%)

16 (39.1%)

Case history

 Diabetes

60 (22.3%)

10 (24.4%)

0.766

 Hypertension

128 (47.6%)

25 (60.0%)

0.131

Medication

 Calcium channel blockers

128 (47.6%)

27 (65.9%)

0.120

 Atorvastatin

255 (94.8%)

41 (100.0%)

0.150

 β-Blockers

229 (85.1%)

36 (87.8%)

0.688

Coronary artery disease

 Triple vessel disease ≥ 50%

66 (24.5%)

12 (29.3%)

0.515

 LAD ≥ 50%

189 (70.3%)

35 (85.4%)

0.176

 LCX ≥ 50%

128 (47.6%)

15 (36.6%)

0.188

 RCA ≥ 50%

134 (49.8%)

20 (48.8%)

0.902

 LMCA ≥ 50%

8 (3.0%)

3 (7.3%)

0.161

 Number of brackets

1.26 ± 0.55

1.39 ± 0.59

0.095